Hjem › Ikke-småcellet lungekreft › California › Lancaster
Kliniske studier for Ikke-småcellet lungekreft i Lancaster, CA
4 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Lancaster (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- City Of Hope - Antelope Valley /ID# 263138, Lancaster
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruttererFase 2
- City of Hope Antelope Valley, Lancaster
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- City of Hope Antelope Valley, Lancaster
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RekruttererFase 2
- City of Hope Antelope Valley, Lancaster
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Lancaster
- Steatotisk leversykdom7 studier
- Crohns sykdom7 studier
- Ulcerøs kolitt7 studier
- Type 2-diabetes4 studier
- Astma4 studier
- Høyt blodtrykk3 studier
- Reaktivt tarmsyndrom3 studier
- Kardiovaskulær sykdom3 studier
- Inflammatorisk tarmsykdom3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.